SCHEMBL29598731

SCHEMBL29598731

CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N(C)C(=O)CNC(=O)[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 1/20 0.63
▸ CALCR P30988 4/20 0.60
▸ NPY2R P49146 7/20 0.59
▸ NPY4R P50391 7/20 0.59
▸ NPY5R Q15761 7/20 0.59
▸ NPY1R P25929 5/20 0.59
▸ TFPI P10646 2/20 0.59
▸ GLP1R P43220 4/20 0.58
▸ GCGR P47871 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30862313 0.97 C5AR1 (0.61) C5AR1CALCRNPY2RNPY4RNPY5R
SCHEMBL29598478 0.92 CALCR (0.62) C5AR1CALCRTFPIGLP1RGCGR
SCHEMBL30495653 0.91 CALCR (0.66) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30432646 0.89 CALCR (0.67) C5AR1CALCRNPY2RNPY4RNPY5R
SCHEMBL31182473 0.89 NPY2R (0.70) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30974086 0.88 C5AR1 (0.65) C5AR1CALCRNPY2RNPY4RNPY5R
SCHEMBL30432128 0.88 CALCR (0.69) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL30495793 0.87 CALCR (0.67) C5AR1CALCRNPY2RNPY4RNPY5R
SCHEMBL29593655 0.87 C5AR1 (0.69) C5AR1NPY2RNPY4RNPY5RNPY1R
SCHEMBL29593954 0.87 C5AR1 (0.69) C5AR1NPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220125837-A1 METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2022-04-28 — — US disclosed
Send feedback